Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency

Click to copy article linkArticle link copied!

This article is cited by 163 publications.

1. Scott D. Midgley, Sofia Bariami, Matthew Habgood, Mark Mackey. Adaptive Lambda Scheduling: A Method for Computational Efficiency in Free Energy Perturbation Simulations. Journal of Chemical Information and Modeling 2025, Article ASAP.
2. Maurice Karrenbrock, Alberto Borsatto, Valerio Rizzi, Dominykas Lukauskis, Simone Aureli, Francesco Luigi Gervasio. Absolute Binding Free Energies with OneOPES. The Journal of Physical Chemistry Letters 2024, 15 (39) , 9871-9880. https://doi.org/10.1021/acs.jpclett.4c02352
3. Benjamin Ries, Irfan Alibay, Nithishwer Mouroug Anand, Philip C. Biggin, Aniket Magarkar. Automated Absolute Binding Free Energy Calculation Workflow for Drug Discovery. Journal of Chemical Information and Modeling 2024, 64 (14) , 5357-5364. https://doi.org/10.1021/acs.jcim.4c00343
4. Markus Zehe, Josef Kehrein, Curd Schollmayer, Christina Plank, Helena Kovacs, Eduardo Merino Asumendi, Ulrike Holzgrabe, Clemens Grimm, Christoph Sotriffer. Combined In-Solution Fragment Screening and Crystallographic Binding-Mode Analysis with a Two-Domain Hsp70 Construct. ACS Chemical Biology 2024, 19 (2) , 392-406. https://doi.org/10.1021/acschembio.3c00589
5. Jeffry Setiadi, Simon Boothroyd, David R. Slochower, David L. Dotson, Matthew W. Thompson, Jeffrey R. Wagner, Lee-Ping Wang, Michael K. Gilson. Tuning Potential Functions to Host–Guest Binding Data. Journal of Chemical Theory and Computation 2024, 20 (1) , 239-252. https://doi.org/10.1021/acs.jctc.3c01050
6. Jerome Eberhardt, Stefano Forli. WaterKit: Thermodynamic Profiling of Protein Hydration Sites. Journal of Chemical Theory and Computation 2023, 19 (9) , 2535-2556. https://doi.org/10.1021/acs.jctc.2c01087
7. Gianni Chessari, Ian R. Hardcastle, Jong Sook Ahn, Burcu Anil, Elizabeth Anscombe, Ruth H. Bawn, Luke D. Bevan, Timothy J. Blackburn, Ildiko Buck, Celine Cano, Benoit Carbain, Juan Castro, Ben Cons, Sarah J. Cully, Jane A. Endicott, Lynsey Fazal, Bernard T. Golding, Roger J. Griffin, Karen Haggerty, Suzannah J. Harnor, Keisha Hearn, Stephen Hobson, Rhian S. Holvey, Steven Howard, Claire E. Jennings, Christopher N. Johnson, John Lunec, Duncan C. Miller, David R. Newell, Martin E. M. Noble, Judith Reeks, Charlotte H. Revill, Christiane Riedinger, Jeffrey D. St. Denis, Emiliano Tamanini, Huw Thomas, Neil T. Thompson, Mladen Vinković, Stephen R. Wedge, Pamela A. Williams, Nicola E. Wilsher, Bian Zhang, Yan Zhao. Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction. Journal of Medicinal Chemistry 2021, 64 (7) , 4071-4088. https://doi.org/10.1021/acs.jmedchem.0c02188
8. David S. Huang, Emmanuelle V. LeBlanc, Tanvi Shekhar-Guturja, Nicole Robbins, Damian J. Krysan, Juan Pizarro, Luke Whitesell, Leah E. Cowen, Lauren E. Brown. Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors. Journal of Medicinal Chemistry 2020, 63 (5) , 2139-2180. https://doi.org/10.1021/acs.jmedchem.9b00826
9. Li Li, Lei Wang, Qi-Dong You, Xiao-Li Xu. Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. Journal of Medicinal Chemistry 2020, 63 (5) , 1798-1822. https://doi.org/10.1021/acs.jmedchem.9b00940
10. Fabrizio Giordanetto, Chentian Jin, Lindsay Willmore, Miklos Feher, David E. Shaw. Fragment Hits: What do They Look Like and How do They Bind?. Journal of Medicinal Chemistry 2019, 62 (7) , 3381-3394. https://doi.org/10.1021/acs.jmedchem.8b01855
11. Denis Bucher, Pieter Stouten, Nicolas Triballeau. Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based Methods. Journal of Chemical Information and Modeling 2018, 58 (3) , 692-699. https://doi.org/10.1021/acs.jcim.7b00642
12. Anuj Khandelwal, Vincent M. Crowley, and Brian S. J. Blagg . Resorcinol-Based Grp94-Selective Inhibitors. ACS Medicinal Chemistry Letters 2017, 8 (10) , 1013-1018. https://doi.org/10.1021/acsmedchemlett.7b00193
13. Jeffrey R. Wagner, Jesper Sørensen, Nathan Hensley, Celia Wong, Clare Zhu, Taylor Perison, and Rommie E. Amaro . POVME 3.0: Software for Mapping Binding Pocket Flexibility. Journal of Chemical Theory and Computation 2017, 13 (9) , 4584-4592. https://doi.org/10.1021/acs.jctc.7b00500
14. Shipra Malhotra and John Karanicolas . When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?. Journal of Medicinal Chemistry 2017, 60 (1) , 128-145. https://doi.org/10.1021/acs.jmedchem.6b00725
15. Magdalena Korczynska, Daniel D. Le, Noah Younger, Elisabet Gregori-Puigjané, Anthony Tumber, Tobias Krojer, Srikannathasan Velupillai, Carina Gileadi, Radosław P. Nowak, Eriko Iwasa, Samuel B. Pollock, Idelisse Ortiz Torres, Udo Oppermann, Brian K. Shoichet, and Danica Galonić Fujimori . Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors. Journal of Medicinal Chemistry 2016, 59 (4) , 1580-1598. https://doi.org/10.1021/acs.jmedchem.5b01527
16. Shane M. Devine, Mark D. Mulcair, Cael O. Debono, Eleanor W. W. Leung, J. Willem M. Nissink, San Sui Lim, Indu R. Chandrashekaran, Mansha Vazirani, Biswaranjan Mohanty, Jamie S. Simpson, Jonathan B. Baell, Peter J. Scammells, Raymond S. Norton, and Martin J. Scanlon . Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold. Journal of Medicinal Chemistry 2015, 58 (3) , 1205-1214. https://doi.org/10.1021/jm501402x
17. Bernard Pirard and Peter Ertl . Evaluation of a Semi-Automated Workflow for Fragment Growing. Journal of Chemical Information and Modeling 2015, 55 (1) , 180-193. https://doi.org/10.1021/ci5006355
18. Elisa Barile and Maurizio Pellecchia . NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein–Protein Interactions. Chemical Reviews 2014, 114 (9) , 4749-4763. https://doi.org/10.1021/cr500043b
19. P. Bisignano, S. Doerr, M. J. Harvey, A. D. Favia, A. Cavalli, and G. De Fabritiis . Kinetic Characterization of Fragment Binding in AmpC β-Lactamase by High-Throughput Molecular Simulations. Journal of Chemical Information and Modeling 2014, 54 (2) , 362-366. https://doi.org/10.1021/ci4006063
20. Kamran Haider and David J. Huggins . Combining Solvent Thermodynamic Profiles with Functionality Maps of the Hsp90 Binding Site to Predict the Displacement of Water Molecules. Journal of Chemical Information and Modeling 2013, 53 (10) , 2571-2586. https://doi.org/10.1021/ci4003409
21. Elinor Meiby, Heather Simmonite, Loic le Strat, Ben Davis, Natalia Matassova, Jonathan D. Moore, Michael Mrosek, James Murray, Roderick E. Hubbard, and Sten Ohlson . Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90. Analytical Chemistry 2013, 85 (14) , 6756-6766. https://doi.org/10.1021/ac400715t
22. Russell R. A. Kitson and Christopher J. Moody . Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90. The Journal of Organic Chemistry 2013, 78 (11) , 5117-5141. https://doi.org/10.1021/jo4002849
23. Pan Wu, Robin Chaudret, Xiangqian Hu, and Weitao Yang . Noncovalent Interaction Analysis in Fluctuating Environments. Journal of Chemical Theory and Computation 2013, 9 (5) , 2226-2234. https://doi.org/10.1021/ct4001087
24. Laurent Hoffer, Jean-Paul Renaud, and Dragos Horvath . In Silico Fragment-Based Drug Discovery: Setup and Validation of a Fragment-to-Lead Computational Protocol Using S4MPLE. Journal of Chemical Information and Modeling 2013, 53 (4) , 836-851. https://doi.org/10.1021/ci4000163
25. Tian Zhu, Hyun Lee, Hao Lei, Christopher Jones, Kavankumar Patel, Michael E. Johnson, and Kirk E. Hevener . Fragment-Based Drug Discovery Using a Multidomain, Parallel MD-MM/PBSA Screening Protocol. Journal of Chemical Information and Modeling 2013, 53 (3) , 560-572. https://doi.org/10.1021/ci300502h
26. Laurent Hoffer and Dragos Horvath . S4MPLE – Sampler For Multiple Protein–Ligand Entities: Simultaneous Docking of Several Entities. Journal of Chemical Information and Modeling 2013, 53 (1) , 88-102. https://doi.org/10.1021/ci300495r
27. Paola Bisignano, Chiara Lambruschini, Manuele Bicego, Vittorio Murino, Angelo D. Favia, and Andrea Cavalli . In Silico Deconstruction of ATP-Competitive Inhibitors of Glycogen Synthase Kinase-3β. Journal of Chemical Information and Modeling 2012, 52 (12) , 3233-3244. https://doi.org/10.1021/ci300355p
28. Bhavesh H. Patel and Anthony G. M. Barrett . Total Synthesis of Resorcinol Amide Hsp90 Inhibitor AT13387. The Journal of Organic Chemistry 2012, 77 (24) , 11296-11301. https://doi.org/10.1021/jo302406w
29. Dipen M. Shah, Eiso AB, Tammo Diercks, Mathias A. S. Hass, Nico A. J. van Nuland, and Gregg Siegal . Rapid Protein–Ligand Costructures from Sparse NOE Data. Journal of Medicinal Chemistry 2012, 55 (23) , 10786-10790. https://doi.org/10.1021/jm301396d
30. Duncan E. Scott, Anthony G. Coyne, Sean A. Hudson, and Chris Abell . Fragment-Based Approaches in Drug Discovery and Chemical Biology. Biochemistry 2012, 51 (25) , 4990-5003. https://doi.org/10.1021/bi3005126
31. Isabelle Krimm, Jean-Marc Lancelin, and Jean-Pierre Praly . Binding Evaluation of Fragment-Based Scaffolds for Probing Allosteric Enzymes. Journal of Medicinal Chemistry 2012, 55 (3) , 1287-1295. https://doi.org/10.1021/jm201439b
32. Hannah J. Maple, Rachel A. Garlish, Laura Rigau-Roca, John Porter, Ian Whitcombe, Christine E. Prosser, Jeff Kennedy, Alistair J. Henry, Richard J. Taylor, Matthew P. Crump, and John Crosby . Automated Protein–Ligand Interaction Screening by Mass Spectrometry. Journal of Medicinal Chemistry 2012, 55 (2) , 837-851. https://doi.org/10.1021/jm201347k
33. Bernd Kuhn, Julian E. Fuchs, Michael Reutlinger, Martin Stahl, and Neil R. Taylor . Rationalizing Tight Ligand Binding through Cooperative Interaction Networks. Journal of Chemical Information and Modeling 2011, 51 (12) , 3180-3198. https://doi.org/10.1021/ci200319e
34. James E. H. Day, Swee Y. Sharp, Martin G. Rowlands, Wynne Aherne, Angela Hayes, Florence I. Raynaud, William Lewis, S. Mark Roe, Chrisostomos Prodromou, Laurence H. Pearl, Paul Workman, and Christopher J. Moody . Targeting the Hsp90 Molecular Chaperone with Novel Macrolactams. Synthesis, Structural, Binding, and Cellular Studies. ACS Chemical Biology 2011, 6 (12) , 1339-1347. https://doi.org/10.1021/cb200196e
35. Roman A. Laskowski and Mark B. Swindells . LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery. Journal of Chemical Information and Modeling 2011, 51 (10) , 2778-2786. https://doi.org/10.1021/ci200227u
36. Stephen D. Roughley and Roderick E. Hubbard . How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90. Journal of Medicinal Chemistry 2011, 54 (12) , 3989-4005. https://doi.org/10.1021/jm200350g
37. Andrew J. Woodhead, Hayley Angove, Maria G. Carr, Gianni Chessari, Miles Congreve, Joseph E. Coyle, Jose Cosme, Brent Graham, Philip J. Day, Robert Downham, Lynsey Fazal, Ruth Feltell, Eva Figueroa, Martyn Frederickson, Jonathan Lewis, Rachel McMenamin, Christopher W. Murray, M. Alistair O’Brien, Lina Parra, Sahil Patel, Theresa Phillips, David C. Rees, Sharna Rich, Donna-Michelle Smith, Gary Trewartha, Mladen Vinkovic, Brian Williams and Alison J.-A. Woolford . Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design. Journal of Medicinal Chemistry 2010, 53 (16) , 5956-5969. https://doi.org/10.1021/jm100060b
38. Shiuan-Po Wang, Jilliane Clare Lu, Woo-Jin Yoo. Synthesis of 3-hydroxybenzoic acid derivatives via photochemical rearrangement of 6-substituted bicyclo[3.1.0]hex-3-en-2-ones. Canadian Journal of Chemistry 2024, 102 (11) , 772-777. https://doi.org/10.1139/cjc-2023-0234
39. Yaosen Min, Ye Wei, Peizhuo Wang, Xiaoting Wang, Han Li, Nian Wu, Stefan Bauer, Shuxin Zheng, Yu Shi, Yingheng Wang, Ji Wu, Dan Zhao, Jianyang Zeng. From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning. Advanced Science 2024, 11 (40) https://doi.org/10.1002/advs.202405404
40. Rong-Hong Zhang, Guo-Qi Chen, Weilin Wang, Yu-Chan Wang, Wen-Li Zhang, Ting Chen, Qian-Qian Xiong, Yong-Long Zhao, Shang-Gao Liao, Yong-Jun Li, Guo-Yi Yan, Meng Zhou. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as novel HIV-1 integrase strand transfer inhibitors. RSC Advances 2024, 14 (13) , 9020-9031. https://doi.org/10.1039/D3RA08320A
41. Shaoqing Du, Xueping Hu, Luis Menéndez-Arias, Peng Zhan, Xinyong Liu. Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges. Drug Resistance Updates 2024, 73 , 101053. https://doi.org/10.1016/j.drup.2024.101053
42. Maged E. Mohamed, Azza M. El-Shafae, Eman Fikry, Samar S. Elbaramawi, Mahmoud H. Elbatreek, Nora Tawfeek. Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies. Frontiers in Pharmacology 2023, 14 https://doi.org/10.3389/fphar.2023.1322181
43. Xin Xie, Nan Zhang, Xiang Li, He Huang, Cheng Peng, Wei Huang, Leonard J. Foster, Gu He, Bo Han. Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy. Bioorganic Chemistry 2023, 139 , 106721. https://doi.org/10.1016/j.bioorg.2023.106721
44. Carmen Avendaño, J. Carlos Menéndez. Miscellaneous small- molecule and biological approaches to targeted cancer therapy. 2023, 743-822. https://doi.org/10.1016/B978-0-12-818549-0.00016-9
45. Saba Rezvani, Ahmad Ebadi, Nima Razzaghi-Asl. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 2022, 40 (21) , 10665-10676. https://doi.org/10.1080/07391102.2021.1947383
46. Irfan Alibay, Aniket Magarkar, Daniel Seeliger, Philip Charles Biggin. Evaluating the use of absolute binding free energy in the fragment optimisation process. Communications Chemistry 2022, 5 (1) https://doi.org/10.1038/s42004-022-00721-4
47. Zi-Nan Li, Ying Luo. HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review). Oncology Reports 2022, 49 (1) https://doi.org/10.3892/or.2022.8443
48. Maged E. Mohamed, Nora Tawfeek, Samar S. Elbaramawi, Mahmoud H. Elbatreek, Eman Fikry. Agathis robusta Bark Extract Protects from Renal Ischemia-Reperfusion Injury: Phytochemical, In Silico and In Vivo Studies. Pharmaceuticals 2022, 15 (10) , 1270. https://doi.org/10.3390/ph15101270
49. Jing Yu, Chao Zhang, Chun Song. Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances. European Journal of Medicinal Chemistry 2022, 238 , 114516. https://doi.org/10.1016/j.ejmech.2022.114516
50. Daniel Alvarez-Garcia, Peter Schmidtke, Elena Cubero, Xavier Barril. Extracting Atomic Contributions to Binding Free Energy Using Molecular Dynamics Simulations with Mixed Solvents (MDmix). Current Drug Discovery Technologies 2022, 19 (2) https://doi.org/10.2174/1570163819666211223162829
51. Lei Wang, Qiuyue Zhang, Qidong You. Targeting the HSP90–CDC37–kinase chaperone cycle: A promising therapeutic strategy for cancer. Medicinal Research Reviews 2022, 42 (1) , 156-182. https://doi.org/10.1002/med.21807
52. Sanket J. Mishra, Anuj Khandelwal, Monimoy Banerjee, Maurie Balch, Shuxia Peng, Rachel E. Davis, Taylor Merfeld, Vitumbiko Munthali, Junpeng Deng, Robert L. Matts, Brian S. J. Blagg. Selective Inhibition of the Hsp90α Isoform. Angewandte Chemie 2021, 133 (19) , 10641-10645. https://doi.org/10.1002/ange.202015422
53. Sanket J. Mishra, Anuj Khandelwal, Monimoy Banerjee, Maurie Balch, Shuxia Peng, Rachel E. Davis, Taylor Merfeld, Vitumbiko Munthali, Junpeng Deng, Robert L. Matts, Brian S. J. Blagg. Selective Inhibition of the Hsp90α Isoform. Angewandte Chemie International Edition 2021, 60 (19) , 10547-10551. https://doi.org/10.1002/anie.202015422
54. Monimoy Banerjee, Ishita Hatial, Bradley M. Keegan, Brian S.J. Blagg. Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases. Pharmacology & Therapeutics 2021, 221 , 107747. https://doi.org/10.1016/j.pharmthera.2020.107747
55. Leonardo L.G. Ferreira, Adriano D. Andricopulo. Structure‐Based Drug Design. 2021, 1-54. https://doi.org/10.1002/0471266949.bmc141.pub2
56. Jeffrey D. St. Denis, Richard J. Hall, Christopher W. Murray, Tom D. Heightman, David C. Rees. Fragment-based drug discovery: opportunities for organic synthesis. RSC Medicinal Chemistry 2021, 12 (3) , 321-329. https://doi.org/10.1039/D0MD00375A
57. Divya Gupta, Asad U. Khan. Advances in Docking-Based Drug Design for Microbial and Cancer Drug Targets. 2021, 407-424. https://doi.org/10.1016/B978-0-12-822312-3.00020-5
58. Sohaib Nizami, Kanisa Arunasalam, Jack Green, James Cook, Catherine B. Lawrence, Tryfon Zarganes‐Tzitzikas, John B. Davis, Elena Di Daniel, David Brough. Inhibition of the NLRP3 inflammasome by HSP90 inhibitors. Immunology 2021, 162 (1) , 84-91. https://doi.org/10.1111/imm.13267
59. Reyal S. Hoxie, Timothy O. Street. Hsp90 chaperones have an energetic hot‐spot for binding inhibitors. Protein Science 2020, 29 (10) , 2101-2111. https://doi.org/10.1002/pro.3933
60. Abdul-Hamid Emwas, Kacper Szczepski, Benjamin Gabriel Poulson, Kousik Chandra, Ryan T. McKay, Manel Dhahri, Fatimah Alahmari, Lukasz Jaremko, Joanna Izabela Lachowicz, Mariusz Jaremko. NMR as a “Gold Standard” Method in Drug Design and Discovery. Molecules 2020, 25 (20) , 4597. https://doi.org/10.3390/molecules25204597
61. Brandon R. Rosen, Ehesan Ul Sharif, Dillon H. Miles, Nicholas S. Chan, Manmohan R. Leleti, Jay P. Powers. Improved synthesis of sterically encumbered heteroaromatic biaryls from aromatic β-keto esters. Tetrahedron Letters 2020, 61 (20) , 151855. https://doi.org/10.1016/j.tetlet.2020.151855
62. Jackee Sanchez, Trever R. Carter, Mark S. Cohen, Brian S.J. Blagg. Old and New Approaches to Target the Hsp90 Chaperone. Current Cancer Drug Targets 2020, 20 (4) , 253-270. https://doi.org/10.2174/1568009619666191202101330
63. Xiao Hu, Irene Maffucci, Alessandro Contini. Advances in the Treatment of Explicit Water Molecules in Docking and Binding Free Energy Calculations. Current Medicinal Chemistry 2020, 26 (42) , 7598-7622. https://doi.org/10.2174/0929867325666180514110824
64. György G. Ferenczy, György M. Keserű. Thermodynamic profiling for fragment-based lead discovery and optimization. Expert Opinion on Drug Discovery 2020, 15 (1) , 117-129. https://doi.org/10.1080/17460441.2020.1691166
65. Peter W. Kenny. The nature of ligand efficiency. Journal of Cheminformatics 2019, 11 (1) https://doi.org/10.1186/s13321-019-0330-2
66. Zhiqiang Wang, Guanglei Zuo, Seung Hwan Hwang, Shin Hwa Kwon, Young-Hee Kang, Jae-Yong Lee, Soon Sung Lim. Affinity measurement of ligands in Perilla frutescens extract towards α-glucosidase using affinity-based ultrafiltration-high-performance liquid chromatography. Journal of Chromatography B 2019, 1125 , 121725. https://doi.org/10.1016/j.jchromb.2019.121725
67. Claudio Dalvit, Annick Parent, Francois Vallée, Magali Mathieu, Alexey Rak. Fast NMR Methods for Measuring in the Direct and/or Competition Mode the Dissociation Constants of Chemical Fragments Interacting with a Receptor. ChemMedChem 2019, 14 (11) , 1115-1127. https://doi.org/10.1002/cmdc.201900152
68. Jatinder Kaur, Atul Bhardwaj, Bruce J. Melancon, Brian S. J. Blagg. The succinct synthesis of AT13387, a clinically relevant Hsp90 inhibitor. Synthetic Communications 2019, 49 (11) , 1436-1443. https://doi.org/10.1080/00397911.2019.1602654
69. Dario Valenti, Stanimira Hristeva, Dimitrios Tzalis, Christian Ottmann. Clinical candidates modulating protein-protein interactions: The fragment-based experience. European Journal of Medicinal Chemistry 2019, 167 , 76-95. https://doi.org/10.1016/j.ejmech.2019.01.084
70. Tai Wang, Anna Rodina, Mark P. Dunphy, Adriana Corben, Shanu Modi, Monica L. Guzman, Daniel T. Gewirth, Gabriela Chiosis. Chaperome heterogeneity and its implications for cancer study and treatment. Journal of Biological Chemistry 2019, 294 (6) , 2162-2179. https://doi.org/10.1074/jbc.REV118.002811
71. Prathap Somu, Subhankar Paul. HSP90 and Its Inhibitors for Cancer Therapy: Use of Nano-delivery System to Improve Its Clinical Application. 2019, 159-182. https://doi.org/10.1007/978-3-030-23158-3_8
72. Swadesh K. Das, Devanand Sarkar, Luni Emdad, Paul B. Fisher. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis. 2019, 137-191. https://doi.org/10.1016/bs.acr.2019.03.011
73. Vladimir I. Polshakov, Evgeniy A. Batuev, Alexey B. Mantsyzov. NMR screening and studies of target – ligand interactions. Russian Chemical Reviews 2019, 88 (1) , 59-98. https://doi.org/10.1070/RCR4836
74. Claire Raingeval, Olivier Cala, Béatrice Brion, Marc Le Borgne, Roderick Eliot Hubbard, Isabelle Krimm. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery. Journal of Enzyme Inhibition and Medicinal Chemistry 2019, 34 (1) , 1218-1225. https://doi.org/10.1080/14756366.2019.1636235
75. Anuj Khandelwal, Caitlin N. Kent, Maurie Balch, Shuxia Peng, Sanket J. Mishra, Junpeng Deng, Victor W. Day, Weiya Liu, Chitra Subramanian, Mark Cohen, Jeffery M. Holzbeierlein, Robert Matts, Brian S. J. Blagg. Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. Nature Communications 2018, 9 (1) https://doi.org/10.1038/s41467-017-02013-1
76. Giusy Tassone, Stefano Mangani, Maurizio Botta, Cecilia Pozzi. Probing the role of Arg97 in Heat shock protein 90 N-terminal domain from the parasite Leishmania braziliensis through site-directed mutagenesis on the human counterpart. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2018, 1866 (11) , 1190-1198. https://doi.org/10.1016/j.bbapap.2018.09.005
77. Po-chia Chen, Janosch Hennig. The role of small-angle scattering in structure-based screening applications. Biophysical Reviews 2018, 10 (5) , 1295-1310. https://doi.org/10.1007/s12551-018-0464-x
78. Mathilde Lescanne, Puneet Ahuja, Anneloes Blok, Monika Timmer, Tomas Akerud, Marcellus Ubbink. Methyl group reorientation under ligand binding probed by pseudocontact shifts. Journal of Biomolecular NMR 2018, 71 (4) , 275-285. https://doi.org/10.1007/s10858-018-0190-5
79. Ming Chu, Xi Chen, Jing Wang, Likai Guo, Qianqian Wang, Zirui Gao, Jiarui Kang, Mingbo Zhang, Jinqiu Feng, Qi Guo, Binghua Li, Chengrui Zhang, Xueyuan Guo, Zhengyun Chu, Yuedan Wang. Polypharmacology of Berberine Based on Multi-Target Binding Motifs. Frontiers in Pharmacology 2018, 9 https://doi.org/10.3389/fphar.2018.00801
80. Jianzhong Chen, Jinan Wang, Fengbo Lai, Wei Wang, Laixue Pang, Weiliang Zhu. Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations. RSC Advances 2018, 8 (45) , 25456-25467. https://doi.org/10.1039/C8RA05042B
81. Jacob Robson-Tull. Biophysical screening in fragment-based drug design: a brief overview. Bioscience Horizons: The International Journal of Student Research 2018, 11 https://doi.org/10.1093/biohorizons/hzy015
82. , , Amanda J. Price, Steven Howard, Benjamin D. Cons. Fragment-based drug discovery and its application to challenging drug targets. Essays in Biochemistry 2017, 61 (5) , 475-484. https://doi.org/10.1042/EBC20170029
83. Glyn Williams, György G. Ferenczy, Johan Ulander, György M. Keserű. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery. Drug Discovery Today 2017, 22 (4) , 681-689. https://doi.org/10.1016/j.drudis.2016.11.019
84. Sergio Ruiz-Carmona, Peter Schmidtke, F. Javier Luque, Lisa Baker, Natalia Matassova, Ben Davis, Stephen Roughley, James Murray, Rod Hubbard, Xavier Barril. Dynamic undocking and the quasi-bound state as tools for drug discovery. Nature Chemistry 2017, 9 (3) , 201-206. https://doi.org/10.1038/nchem.2660
85. H. Chen, X. Zhou, Y. Gao, H. Chen, J. Zhou. Fragment-Based Drug Design: Strategic Advances and Lessons Learned. 2017, 212-232. https://doi.org/10.1016/B978-0-12-409547-2.12319-4
86. A Elisa Pasqua, B. Wilding, M.D. Cheeseman, K. Jones. Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer. 2017, 202-280. https://doi.org/10.1016/B978-0-12-409547-2.12395-9
87. Ben J. Davis, Stephen D. Roughley. Fragment-Based Lead Discovery. 2017, 371-439. https://doi.org/10.1016/bs.armc.2017.07.002
88. Hsiao-Ling Huang, Inna V. Krieger, Maloy K. Parai, Vijay B. Gawandi, James C. Sacchettini. Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange. Journal of Biological Chemistry 2016, 291 (53) , 27421-27432. https://doi.org/10.1074/jbc.M116.750877
89. Bradley C. Doak, Raymond S. Norton, Martin J. Scanlon. The ways and means of fragment-based drug design. Pharmacology & Therapeutics 2016, 167 , 28-37. https://doi.org/10.1016/j.pharmthera.2016.07.003
90. Antonia S.J.S. Mey, Jordi Juárez-Jiménez, Alexis Hennessy, Julien Michel. Blinded predictions of binding modes and energies of HSP90-α ligands for the 2015 D3R grand challenge. Bioorganic & Medicinal Chemistry 2016, 24 (20) , 4890-4899. https://doi.org/10.1016/j.bmc.2016.07.044
91. Nanjie Deng, William F. Flynn, Junchao Xia, R. S. K. Vijayan, Baofeng Zhang, Peng He, Ahmet Mentes, Emilio Gallicchio, Ronald M. Levy. Large scale free energy calculations for blind predictions of protein–ligand binding: the D3R Grand Challenge 2015. Journal of Computer-Aided Molecular Design 2016, 30 (9) , 743-751. https://doi.org/10.1007/s10822-016-9952-x
92. Veronica Salmaso, Mattia Sturlese, Alberto Cuzzolin, Stefano Moro. DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015. Journal of Computer-Aided Molecular Design 2016, 30 (9) , 773-789. https://doi.org/10.1007/s10822-016-9966-4
93. Kyu-Yeon Jun, Youngjoo Kwon. Proposal of Dual Inhibitor Targeting ATPase Domains of Topoisomerase II and Heat Shock Protein 90. Biomolecules & Therapeutics 2016, 24 (5) , 453-468. https://doi.org/10.4062/biomolther.2016.168
94. Roberta Marchetti, Serge Perez, Ana Arda, Anne Imberty, Jesus Jimenez-Barbero, Alba Silipo, Antonio Molinaro. “Rules of Engagement” of Protein-Glycoconjugate Interactions: A Molecular View Achievable by using NMR Spectroscopy and Molecular Modeling. ChemistryOpen 2016, 5 (4) , 274-296. https://doi.org/10.1002/open.201600024
95. King Tuo Yip, Xue Yin Zhong, Nadia Seibel, Stefanie Pütz, Jasmin Autzen, Raphael Gasper, Eckhard Hofmann, Jürgen Scherkenbeck, Raphael Stoll. Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma. Scientific Reports 2016, 6 (1) https://doi.org/10.1038/srep25119
96. Arun Chandramohan, Srinath Krishnamurthy, Andreas Larsson, Paer Nordlund, Anna Jansson, Ganesh S. Anand, . Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design. PLOS Computational Biology 2016, 12 (6) , e1004840. https://doi.org/10.1371/journal.pcbi.1004840
97. Roderick E. Hubbard. The Role of Fragment‐based Discovery in Lead Finding. 2016, 1-36. https://doi.org/10.1002/9783527683604.ch01
98. Christopher W. Murray, David C. Rees. Organische Chemie für die fragmentbasierte Wirkstoffentwicklung (FBDD). Angewandte Chemie 2016, 128 (2) , 498-503. https://doi.org/10.1002/ange.201506783
99. Christopher W. Murray, David C. Rees. Opportunity Knocks: Organic Chemistry for Fragment‐Based Drug Discovery (FBDD). Angewandte Chemie International Edition 2016, 55 (2) , 488-492. https://doi.org/10.1002/anie.201506783
100. Byeonggu Han, Hee-Chul Ahn. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy. 2016, 35-46. https://doi.org/10.1007/978-1-4939-3073-9_3